Maximus Tribe operates a GLP-1 telehealth weight-loss track as of April 2026, meaning a licensed provider can prescribe a GLP-1 medication after a virtual evaluation
J Clin Invest (2012) 122(1):388402.10.1172/JCI42497 38 AoyamaEWatariIPodyma-InoueKAYanagishitaMOnoT
An ongoing phase 3 trial, the SELECT study, will evaluate the cardiovascular benefit of semaglutide beyond blood glucose control, as the study population is composed of individuals who are overweight or obese without diabetes [81]
A pilot study subsequently conducted by Holst in collaboration with Mette Zander at Hvidovre Hospital between September 1999 and October 2000 indicated that continuous subcutaneous infusions of synthetic GLP-1 over 6 weeks into patients with quite severe type 2 diabetes dramatically improved their blood sugar control, lowered glycated haemoglobin levels and decreased their body weight
There are oral versions of these medications, but they are not yet approved for weight loss
Let Clean Eatz handle the nutrition